Tam, C. S., Abruzzo, L. V., Lin, K. I., Cortes, J., Lynn, A., Keating, M. J., . . . Verstovsek, S. (2009). The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: Applicability at the time of diagnosis and later during disease course. Blood.
Chicago Style CitationTam, Constantine S., et al. "The Role of Cytogenetic Abnormalities As a Prognostic Marker in Primary Myelofibrosis: Applicability At the Time of Diagnosis and Later During Disease Course." Blood 2009.
Cita MLATam, Constantine S., et al. "The Role of Cytogenetic Abnormalities As a Prognostic Marker in Primary Myelofibrosis: Applicability At the Time of Diagnosis and Later During Disease Course." Blood 2009.
Atenció: Aquestes cites poden no estar 100% correctes.